Ronald Congemi V - 01 Oct 2021 Form 4 Insider Report for Everi Holdings Inc. (EVRI)

Role
Director
Signature
/s/ Ronald V. Congemi by Todd A. Valli, Attorney-in-Fact
Issuer symbol
EVRI
Transactions as of
01 Oct 2021
Net transactions value
-$286,000
Form type
4
Filing time
05 Oct 2021, 19:33:02 UTC
Previous filing
28 Sep 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVRI Common Stock Options Exercise $71,000 +10,000 +62% $7.10 26,000 01 Oct 2021 Direct F1
transaction EVRI Common Stock Options Exercise $35,500 +5,000 +19% $7.10 31,000 05 Oct 2021 Direct F1
transaction EVRI Common Stock Sale $260,000 -10,000 -32% $26.00 21,000 01 Oct 2021 Direct F1, F2
transaction EVRI Common Stock Sale $132,500 -5,000 -24% $26.50 16,000 05 Oct 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVRI Stock Option Options Exercise $0 -10,000 -12% $0.000000 75,000 01 Oct 2021 Common Stock 10,000 $7.10 Direct F4
transaction EVRI Stock Option Options Exercise $0 -5,000 -6.7% $0.000000 70,000 05 Oct 2021 Common Stock 5,000 $7.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 12, 2021 for options originally granted on February 28, 2013.
F2 The shares were sold in multiple transactions at a price of $26.00. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction at the price set forth in this footnote.
F3 The shares were sold in multiple transactions at a price of $26.50. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction at the price set forth in this footnote.
F4 Represents an option to purchase 100,000 shares of the Company's common stock, which vested periodically over a period of four years following the date of grant.